Smarter Studies. Global Impact. Better Health.

The MRC Clinical Trials Unit (MRC CTU) at UCL is at the forefront of resolving internationally important questions in infectious diseases and cancer, and delivering swifter and more effective translation of scientific research into patient benefits.

Latest News and Updates

The 50th Union World Conference on Lung Health

MRC Clinical Trials Unit at UCL will be presenting results from the STREAM tuberculosis trial.

30 Oct

STAMPEDE provides further insight into treating prostate cancer

Further results from the STAMPEDE trial have been presented at European Society for Medical Oncology Congress 2019 over the last few days

30 Sep

Active observation still the best treatment for kidney cancer patients at medium or high risk of their cancer coming back after surgery

Active observation remains the best treatment for patients who are at medium or high risk of their cancer coming back after surgery to remove their kidney cancer.

28 Sep

More men with prostate cancer can be spared radiotherapy after surgery

The RADICALS-RT trial looked at 1396 men with prostate cancer after they had surgery to remove the cancer.

27 Sep

Our Research Themes

Cancer

Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types

Infections

Major international clinical trials answering questions of global public health significance

Methodology

Development of methods with direct impact on the design, conduct and analysis of studies

Other Research & Policy

This section will capture projects outside the current QQR themes